Balsamo, Gianna B.
HRN: 28-96-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2026
CEFOTAXIME 500MG (VIAL)
05/16/2026
05/23/2026
IV
90mg
Q12
Neonatal Sepsis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines